The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial
Henning Kelbæk, MD*,*,
Leif Thuesen, MD
,
Steffen Helqvist, MD*,
Lene Kløvgaard, RN*,
Erik Jørgensen, MD*,
Samir Aljabbari, MD*,
Kari Saunamäki, MD*,
Lars R. Krusell, MD
,
Gunnar V.H. Jensen, MD
,
Hans E. Bøtker, MD
,
Jens F. Lassen, MD
,
Henning R. Andersen, MD
,
Per Thayssen, MD
,
Anders Galløe, MD||,
Anton van Weert, PhD¶ for the SCANDSTENT Investigators
* Rigshospitalet, Copenhagen, Denmark
Skejby Sygehus, Skejby, Denmark
Roskilde Amtssygehus, Roskilde, Denmark
Odense Universitets hospital, Odense, Denmark
|| Gentofte Amtssygehus, Gentofte, Denmark
¶ Heart Core, Leiden, the Netherlands

View larger version (19K):
[in a new window]
|
Figure 1 Cumulative frequency of the minimal lumen diameter before (pre), immediately after (post), and six months after (follow-up) stent implantation in patients who received sirolimus-eluting and bare-metal stents.
|
|

View larger version (14K):
[in a new window]
|
Figure 2 Kaplan-Meier estimates of event-free survival among patients who received sirolimus-eluting and bare-metal stents.
|
|

View larger version (22K):
[in a new window]
|
Figure 3 Subgroup analysis for the six-month rate of target lesion revascularization. CI = confidence interval; CX = circumflex; LAD = left anterior descending; RCA = right coronary artery.
|
|
Copyright © 2006 by the American College of Cardiology Foundation.